These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23740898)

  • 1. Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".
    Egawa N; Kitaoka S; Tsukita K; Naitoh M; Takahashi K; Yamamoto T; Adachi F; Kondo T; Okita K; Asaka I; Aoi T; Watanabe A; Yamada Y; Morizane A; Takahashi J; Ayaki T; Ito H; Yoshikawa K; Yamawaki S; Suzuki S; Watanabe D; Hioki H; Kaneko T; Makioka K; Okamoto K; Takuma H; Tamaoka A; Hasegawa K; Nonaka T; Hasegawa M; Kawata A; Yoshida M; Nakahata T; Takahashi R; Marchetto MC; Gage FH; Yamanaka S; Inoue H
    Sci Transl Med; 2013 Jun; 5(188):188lr2. PubMed ID: 23740898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".
    Bilican B; Serio A; Barmada SJ; Nishimura AL; Sullivan GJ; Carrasco M; Phatnani HP; Puddifoot CA; Story D; Fletcher J; Park IH; Friedman BA; Daley GQ; Wyllie DJ; Hardingham GE; Wilmut I; Finkbeiner S; Maniatis T; Shaw CE; Chandran S
    Sci Transl Med; 2013 Jun; 5(188):188le2. PubMed ID: 23740897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug screening for ALS using patient-specific induced pluripotent stem cells.
    Egawa N; Kitaoka S; Tsukita K; Naitoh M; Takahashi K; Yamamoto T; Adachi F; Kondo T; Okita K; Asaka I; Aoi T; Watanabe A; Yamada Y; Morizane A; Takahashi J; Ayaki T; Ito H; Yoshikawa K; Yamawaki S; Suzuki S; Watanabe D; Hioki H; Kaneko T; Makioka K; Okamoto K; Takuma H; Tamaoka A; Hasegawa K; Nonaka T; Hasegawa M; Kawata A; Yoshida M; Nakahata T; Takahashi R; Marchetto MC; Gage FH; Yamanaka S; Inoue H
    Sci Transl Med; 2012 Aug; 4(145):145ra104. PubMed ID: 22855461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
    Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
    Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ALS disease modeling and drug screening using patient-specific iPS cells].
    Egawa N; Inoue H
    Rinsho Shinkeigaku; 2013; 53(11):1020-2. PubMed ID: 24291866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient.
    Bossolasco P; Sassone F; Gumina V; Peverelli S; Garzo M; Silani V
    Stem Cell Res; 2018 Jul; 30():61-68. PubMed ID: 29800782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate ALS therapeutics motor toward "in vitro clinical trials".
    Kim YJ; Lee G
    Cell Stem Cell; 2013 Jun; 12(6):633-4. PubMed ID: 23746968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
    Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
    Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Generation of induced pluripotent stem cells from amyotrophic lateral sclerosis patientcarrying SOD1-V14M mutation].
    Liu X; Chen J; Li X; Gao S; Deng M
    Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(27):2143-7. PubMed ID: 25327864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.
    Dimos JT; Rodolfa KT; Niakan KK; Weisenthal LM; Mitsumoto H; Chung W; Croft GF; Saphier G; Leibel R; Goland R; Wichterle H; Henderson CE; Eggan K
    Science; 2008 Aug; 321(5893):1218-21. PubMed ID: 18669821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique.
    Toli D; Buttigieg D; Blanchard S; Lemonnier T; Lamotte d'Incamps B; Bellouze S; Baillat G; Bohl D; Haase G
    Neurobiol Dis; 2015 Oct; 82():269-280. PubMed ID: 26107889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.
    Winner B; Marchetto MC; Winkler J; Gage FH
    Hum Mol Genet; 2014 Sep; 23(R1):R27-34. PubMed ID: 24821704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
    O'Connor DM; Boulis NM
    Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
    Bhinge A; Namboori SC; Zhang X; VanDongen AMJ; Stanton LW
    Stem Cell Reports; 2017 Apr; 8(4):856-869. PubMed ID: 28366453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells from ALS patients for disease modeling.
    Richard JP; Maragakis NJ
    Brain Res; 2015 May; 1607():15-25. PubMed ID: 25223906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis.
    Almad AA; Doreswamy A; Gross SK; Richard JP; Huo Y; Haughey N; Maragakis NJ
    Glia; 2016 Jul; 64(7):1154-69. PubMed ID: 27083773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosis.
    Bennett JP; O'Brien LC; Brohawn DG
    Biochem Pharmacol; 2016 Oct; 117():68-77. PubMed ID: 27498123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FUS Mutant Human Motoneurons Display Altered Transcriptome and microRNA Pathways with Implications for ALS Pathogenesis.
    De Santis R; Santini L; Colantoni A; Peruzzi G; de Turris V; Alfano V; Bozzoni I; Rosa A
    Stem Cell Reports; 2017 Nov; 9(5):1450-1462. PubMed ID: 28988989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.